EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

One-Stage Versus Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection

Thomas K Fehring iD, Jesse E Otero iD, Keith A Fehring iD, Brian M Curtin, Bryan D Springer iD, Craig J Della Valle, Javad Parvizi iD, Kayla Hietpas iD, Alexis Ready iD, Susan M Odum, the PJI Study Group

Journal of Bone and Joint Surgery · 15.07.2026 · 108 (14) · 1070-1082

DOI: 10.2106/jbjs.25.00713 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 01.04.2026. Verfasst von Thomas K Fehring und 10 weiteren Autor:innen. Beteiligte Einrichtung: OrthoCarolina Hip & Knee Center, Charlotte, North Carolina. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip, Knee Prosthesis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A 2-stage approach is most commonly used to treat periprosthetic joint infection (PJI). Some successful studies of the 1-stage approach were underpowered, lacked a 2-stage comparative group, and excluded patients with draining sinuses, comorbidities, and/or antibiotic-resistant organisms. Given the morbidity and expense associated with 2-stage treatment, we conducted a prospective, multicenter, randomized trial to compare the results of 1- and 2-stage PJI treatment, specifically including patients with draining sinuses, comorbidities, and resistant organisms.

Methods

Patients presenting for surgical treatment of a chronic PJI with a known organism following primary total hip or knee arthroplasty were included (with infection defined by Musculoskeletal Infection Society [MSIS] criteria). Patients with prior revision, culture-negative infection, or fungal infection, or who were immunosuppressed or had soft-tissue involvement precluding wound closure, were excluded. Patients were classified according to the McPherson host staging system. Clinical success was defined as (1) no clinical failure or reinfection with the same or new organism; (2) no reoperation for PJI; and (3) no PJI-related death. A double-instrument setup was used for all patients, as were similar irrigation and antibiotic protocols. A total of 323 patients (166 one-stage; 157 two-stage) were randomized. Groups were similar with respect to demographics and host classification. After excluding patients who died or were lost to follow-up, 258 of the 323 patients had 2-year follow-up (135 one-stage and 123 two-stage). The rate of patient loss to follow-up was similar between the treatment groups.

Results

Sixteen patients in the 1-stage group and 9 patients in the 2-stage group died prior to 2-year follow-up. Overall, the 2-year success rate of 1-stage treatment was 97% (131 of 135), while the success of 2-stage treatment was 91% (112 of 123) (p = 0.04). Compared with the 2-stage group, the 1-stage group had 3-times the odds of overall success in a regression analysis (unadjusted odds ratio = 3.22 [95% confidence interval = 1.0 to 10.38]). After adjusting for specific variables (McPherson host grade, resistant organism, and draining sinuses), 1-stage treatment also had 3-times the odds of success.

Conclusions

The results of this prospective randomized trial indicated that 1-stage treatment (97% success) was statistically noninferior to 2-stage treatment (91% success) when treating chronic PJI following primary total hip or knee arthroplasty, provided the protocols described here are explicitly followed. Extrapolation to other patient cohorts and clinical situations should be avoided. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsArthroplasty, Replacement, KneeArthroplasty, Replacement, HipKnee ProsthesisHip ProsthesisHumansProspective StudiesFemaleReoperationMaleAgedTreatment OutcomeMiddle AgedAnti-Bacterial Agents

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • OrthoCarolina Hip & Knee Center, Charlotte, North Carolina.
  • Adult Reconstruction of Hip and Knee, Mayo Clinic, Jacksonville, Florida.
  • Rush University Medical Center, Chicago, Illinois.
  • Acibadem University, Istanbul, Turkey.
  • OrthoCarolina Research Institute, Charlotte, North Carolina.
  • Atrium Health Musculoskeletal Institute, Charlotte, North Carolina.

ORCID-Profile: Thomas K Fehring, Jesse E Otero, Keith A Fehring, Bryan D Springer, Javad Parvizi, Kayla Hietpas, Alexis Ready

Zitieren

APA

Fehring, T. K., Otero, J. E., Fehring, K. A., Curtin, B. M., Springer, B. D., Della Valle, C. J., Parvizi, J., Hietpas, K., Ready, A., Odum, S. M., & the PJI Study Group (2026). One-Stage Versus Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection. Journal of Bone and Joint Surgery, 108(14), 1070-1082. https://doi.org/10.2106/jbjs.25.00713

Vancouver

Fehring TK, Otero JE, Fehring KA, Curtin BM, Springer BD, Della Valle CJ, et al. One-Stage Versus Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection. Journal of Bone and Joint Surgery. 2026;108(14):1070-1082. doi:10.2106/jbjs.25.00713

BibTeX
@article{Fehring2026,
  author = {Fehring, Thomas K and Otero, Jesse E and Fehring, Keith A and Curtin, Brian M and Springer, Bryan D and Della Valle, Craig J and Parvizi, Javad and Hietpas, Kayla and Ready, Alexis and Odum, Susan M and the PJI Study Group, the PJI Study Group},
  title = {One-Stage Versus Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection},
  journal = {Journal of Bone and Joint Surgery},
  year = {2026},
  volume = {108},
  number = {14},
  pages = {1070--1082},
  doi = {10.2106/jbjs.25.00713}
}
Kostenlos starten →